Streamex Acquires 9.9% Equity Interest in Empress Royalty
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 11 2025
0mins
Streamex has acquired a 9.9% equity interest in Empress Royalty through a strategic share purchase from Terra Capital Natural Resources Fund. Under the executed Share Purchase Agreement, Streamex acquired 12,671,297 common shares of Empress in exchange for 2,443,750 restricted common shares of Streamex at a $5.00 STEX share price, representing a premium to the current market price of STEX and an aggregate transaction value equal to $12,218,751.
Analyst Views on STEX
Wall Street analysts forecast STEX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STEX is 12.00 USD with a low forecast of 12.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.120
Low
12.00
Averages
12.00
High
12.00
Current: 3.120
Low
12.00
Averages
12.00
High
12.00
About STEX
Streamex Corp., formerly BioSig Technologies, Inc., is a real world asset (RWA) tokenization company. The Company with institutional grade infrastructure brings the gold and commodities market on chain, enabled by a gold denominated treasury and tokenization technology powering the modern commodities market. The Company is a wholly owned subsidiary of BioSig Technologies, Inc.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





